Unjha Formulations Ltd Share Price Today - Unjha Formulations Ltd Stock Price Live NSE/BSE

Unjha Formulations Ltd

NSE: BSE: 531762

₹20.29

(-2.26%)

Wed, 08 Apr 2026, 10:28 pm

MTF 5xInvest in Unjha Formulations Ltd with 5x Leverage Buy with MTF

Market Cap0

PE Ratio0

Dividend0

Distribution Services

Food Distributors

24.5K

Unjha Formulations Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
9.07
Net Profit
0.41
P/B
3.11
Sector P/E
38.82
P/E
23.98
EV/EBITDA
14.28
Debt/Equity (Industry)
0.26
Interest Cover (Industry)
10.96
ROCE (Industry)
16.65
RONW (Industry)
14.66
ROE
8.77
ROCE
11.55
Debt/Equity
0
EPS (TTM)
2.32
Dividend Yield
0
Book Value
9.70
Interest Cover
54

Analysis

all

Pros

Unjha Formulations is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Unjha Formulations is profitable, therefore cash runway is not a concern.
Unjha Formulations is profitable, therefore cash runway is not a concern.
Unjha Formulations has no debt, it does not need to be covered by operating cash flow.
Unjha Formulations has no debt, it does not need to be covered by short term assets.

Cons

Unable to evaluate Unjha Formulations's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
Unable to evaluate Unjha Formulations's dividend against the top 25% market benchmark as the company has not reported any payouts.
High level of physical assets or inventory.
Unjha Formulations is not covered by any analysts.
Unjha Formulations used its assets less efficiently than the IN Personal Products industry average last year based on Return on Assets.

Financials

No Result Found

Ratios

No Result Found

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	36.92	36.92	36.92	36.92	36.92
FII	0	0	0	0	0
DII	0	0	0	0	0
Public	63.08	63.08	63.08	63.08	63.08
Government	0	0	0	0	0

Technical Analysis

RSI

44.34

MACD

-0.45

50 DMA

21.42

200 DMA

23.76

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	27.36	23.96	22.13	20.56	18.73	17.16	13.76
Fibonacci	23.96	22.66	21.86	20.56	19.26	18.46	17.16
Camarilla	21.22	20.91	20.60	20.56	19.98	19.67	19.36

Pivots Level: Classic

+6.80

27.36

+3.40

23.96

+1.56

22.13

20.56

Pivot Point

LTP: 19.77

-1.84

18.73

-3.40

17.16

-6.80

13.76

Moving Average

SMAEMA

Period

Value

10-EMA
20.07
20-EMA
20.38
30-EMA
20.71
50-EMA
21.32
100-EMA
22.34
200-EMA
23.30

Announcement Date	Purpose	Action
04 Feb 2026	board-meetings	Quarterly Results
10 Nov 2025	board-meetings	Quarterly Results
04 Jul 2025	agm
08 Jul 2024	agm
06 Oct 2023	egm
13 Jul 2023	agm
13 Jul 2022	agm
16 Jul 2021	agm

Peer Comparison

No Result Found

Unjha Formulations Ltd

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd

Torrent Pharmaceuticals Ltd

Lupin Ltd

Divis Laboratories Ltd

Unjha Formulations Ltd About

Unjha Formulations is engaged in manufactures and sells Isabgol Ayurvedic formulations.

Industry

Pharmaceuticals - Indian - Formulations

Founded

1994

Headquarters

CEO

Jyotindra S Patel

Employees

Contact

Website

http://www.unjhaformulations.com

info@unjhaformulations.com ; unjfor@bsnl.in

Phone

91-2767-282395

Location

Khali Char Rasta, State Highway Ta Sidhpur, Patan, Gujarat, 384151

Year	History
1987	M/s. Unjha Formulations Limited was established as a partnership firm.
1991	The company's sales were Rs.85 lacs. The company's exports were Rs.5.52 lacs.
1994	The company was converted into a Public Limited Company. The company achieved sales of Rs.348.50 lacs. The company's exports were Rs.38.56 lacs.
2007	The company provided an E-mail ID for Investor Complaints.

Client Name	Order Side	QTY	Avg Price	Date
USHA JAWAHARLAL KALRO	Sell	33354	34.99	04 Nov 2024
USHA JAWAHARLAL KALRO	Buy	33354	33.8	04 Nov 2024
MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED	Buy	20161	28.32	07 Aug 2024
MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED	Sell	25515	28.32	07 Aug 2024
SATYA PRAKASH MITTAL HUF	Buy	27333	22.52	06 Feb 2024
PRADEEP KUMAR JAIN	Sell	59535	12.6	13 Dec 2022
BHARAT HASTIMAL JAIN HUF	Buy	39492	11.49	06 Jul 2021
PURSHOTTAM AGARWAL	Sell	37612	11.5	06 Jul 2021
BHARAT HASTIMAL JAIN HUF	Sell	1772	11.87	06 Jul 2021
NARENDRAKUMAR BHAGWANDAS GUPTA	Sell	43065	11.09	21 Jun 2021

Unjha Formulations Ltd News

Unjha Formulations Files Updated SEBI Shareholding Disclosure

Unjha Formulations Limited promoter group disclosed collective shareholding of 1654424 shares (36.92%) as on April 1, 2026, in compliance with SEBI takeover regulations.

02 Apr 2026

companies

Unjha Formulations Q3FY26 Results Show Mixed Performance

Unjha Formulations reported Q3FY26 net sales of ₹440.77 lacs with profit of ₹23.97 lacs. Nine-month revenue reached ₹1230.71 lacs with profit of ₹144.75 lacs, showing strong year-over-year growth.

04 Feb 2026

co actions results

Unjha Formulations Reports Mixed Quarterly Performance with Revenue Decline

Unjha Formulations Limited approved its unaudited financial results for the quarter and half-year ended September 30, 2025. The company reported net sales of Rs 361.71 lacs for the quarter compared to Rs 380.66 lacs in the previous quarter, showing a decline. However, the company achieved a profit of Rs 39.09 lacs for the quarter versus a loss of Rs 11.06 lacs in the prior quarter. For the half-year period, net sales reached Rs 798.15 lacs compared to Rs 776.08 lacs in the same period last year. The company's total assets stood at Rs 668.88 lacs as of September 30, 2025, with equity share capital of Rs 448.05 lacs. The Board meeting was held on November 10, 2025, where these results were approved along with the balance sheet and cash flow statements.

10 Nov 2025

earnings

Unjha Formulations Appoints Siddharth Shah as Company Secretary and Compliance Officer

Unjha Formulations Limited appointed Mr. Siddharth Shah as Company Secretary and Compliance Officer effective October 1, 2025. The appointment was approved in a board meeting held on the same date. Shah is an Associate Member of the Institute of Company Secretaries of India with membership number A67232 and brings over 5 years of professional experience across Compliance, Insolvency, Bankruptcy, Finance, and Taxation. His expertise includes Corporate Laws, Valuation, Audit, Secretarial Compliances, and Due Diligence, with experience working alongside Resolution Professionals, Liquidators, and Registered Valuers under IBC, 2016.

01 Oct 2025

corporate governance

Unjha Formulations Reports Loss in First Quarter Ended June 30, 2025

Unjha Formulations Limited reported a net loss of Rs. 40.64 lakhs for the first quarter ended June 30, 2025, compared to a profit of Rs. 50.76 lakhs in the same period last year. Total income from operations decreased to Rs. 363.40 lakhs from Rs. 395.43 lakhs year-over-year. The company's total expenses rose to Rs. 325.81 lakhs from Rs. 272.54 lakhs in the previous year. Basic and diluted earnings per share stood at negative Rs. 0.91 compared to positive Rs. 1.56 in the corresponding quarter last year. The board meeting was held on August 6, 2025, to approve these unaudited financial results.

06 Aug 2025

earnings

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800